Product Surprises Street #VolatilityWatch

NASDAQ:TXMD   TherapeuticsMD, Inc.
What happened?
There were around 106,000 Imvexxy prescriptions in the second quarter, which was 41% more than during the first three months of the year. Treatment's popularity seems to be accelerating: In July the company recorded 45,500 prescriptions bought and paid for.

TherapeuticsMD was expecting net rev. to reach between $4.5 million and $5.5 million in the second quarter, but surprised the street, recording $6.1 million. Management thinks the current market for Imvexxy exceeds $1.7 billion annually. Looking for re-evaluation of stock price into September.


  • Bullish Harmonic Crab reversal at the 1.414 fib. extension level.
  • #TXMD has been heavily shorted for awhile now, look for shorts trying to cover, to add on pullback(s).
  • Looking for potential continuation trade.
  • Oscillators are flashing "overbought" after parabolic move. I'm not reliant on these oscillator levels but this stock is a stock to WATCH!
  • Be careful chasing at these levels (watch for 382-50 retracement: levels noted on chart)
  • #TXMD seems to have now made a bottom. I will be looking to add on the dips.

Please like and follow so I can continue finding awesome trades. Thank you in advance =)

Tip #12: Fibonacci extension level between 1.272 - 1.414 are major psychological levels for "breathers" and reversals during uptrend/ downtrends.

Disclosure: I do not own #TXMD. I may buy/ sell within the next 72 hours. This is not a note to buy or sell, please do your homework before investing.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.